Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SWEGHO - A PROSPECTIVE NON INTERVENTIONAL STUDY PROTOCOL WITH PRIMARY DATA COLLECTION - ASSESSMENT OF THE LONG TERM TREATMENT OUTCOMES OF GENOTROPIN TREATMENT IN GHD PATIENTS IN SWEDEN

NCT01947894 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01947894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01947894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SWEGHO - A PROSPECTIVE NON INTERVENTIONAL STUDY PROTOCOL WITH PRIMARY DATA COLLECTION - ASSESSMENT OF THE LONG TERM TREATMENT OUTCOMES OF GENOTROPIN TREATMENT IN GHD PATIENTS IN SWEDEN
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 20, 2013
Completion date
October 31, 2018
Enrollment
377 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency